Driving Innovation.
Delivering Impact.

We aim to revolutionize cancer care by transforming how life-saving drugs reach their targets.

Our leadership team has a proven track record for translating science into impact

Team

Team

Annbjørg Falck

Annbjørg Falck

Chief Executive Officer
and Co-founder
Yrr Mørch

Yrr Mørch

Chief Technology Officer
and Co-founder
Torgeir Vaage

Torgeir Vaage

Chief Financial Officer
Sofie Snipstad

Sofie Snipstad

Senior Scientist
Glen Clack

Glen Clack

Contract CMO
Gudrun Trøite

Gudrun Trøite

Head of Operations
Anton Mat

Anton Mat

Business Development

Board of Directors

Board of Directors

Ole J. Dahlberg

Ole J. Dahlberg

Chair of the Board
Cristianne Rijcken

Cristianne Rijcken

Board Member
Eli Grong Aursand

Eli Grong Aursand

Board Member
Jonas Hallén

Jonas Hallén

Board Member
Jan Håbrekke

Jan Håbrekke

Board Member

Scientific partners and advisors

Scientific partners and advisors

Kjersti Flatmark

Kjersti Flatmark

Clinical research and advisor
Wim P. Ceelen

Wim P. Ceelen

Clinical Advisor
Anton Mat

Ron Mathijssen

Clinical Advisor
John Paul Y.C. Shen

John Paul Y.C. Shen

Clinical Advisor
Andreas Åslund

Andreas Åslund

Nanoformulation development and synthesis
Geir Klinkenberg

Geir Klinkenberg

In vitro characterization
Jérémie Parot

Jérémie Parot

Physical/chemical characterization
Mark Tracy

Mark Tracy

CMC
Ruth Schmid

Ruth Schmid

Strategic and scientific advice
Bob Crutchfield

Bob Crutchfield

Business advisor
Arthur Tipton

Arthur Tipton

Business Strategy advisor
Mary Reilly

Mary Reilly

CMC, Clinical and Quality